Platte Valley Womens Healthcare

Platte Valley Womens Healthcare

Services:
Facility Vaping Policy
• Vaping permitted without restriction

Facility Operation (e.g., Private, Public)

• Private for-profit organization

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder

Transitional Services

• Naloxone and overdose education

Ancillary Services

• Integrated primary care services

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Gender Accepted

• Female

Treatment Approaches

• Telemedicine/telehealth therapy
• Brief intervention

Special Programs/Groups Offered

• Pregnant/postpartum women
• Clients who have experienced intimate partner violence, domestic violence
• Seniors or older adults
• Clients who have experienced trauma
• Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
• Young adults
• Clients who have experienced sexual abuse
• Adult women
• Clients with co-occurring pain and substance use disorders
• Clients with co-occurring mental and substance use disorders

Payment/Insurance/Funding Accepted

• Federal military insurance (e.g., TRICARE)
• Cash or self-payment
• SAMHSA funding/block grants
• Private health insurance
• Medicaid
• State-financed health insurance plan other than Medicaid
• Federal, or any government funding for substance use treatment programs
• Medicare

Assessment/Pre-treatment

• Screening for mental disorders
• Screening for tobacco use
• Complete medical history/physical exam
• Comprehensive substance use assessment
• Screening for substance use

External Opioid Medications Source

• Other contracted prescribing entity

Education and Counseling Services

• Family counseling
• Marital/couples counseling
• Substance use disorder education
• Smoking/vaping/tobacco cessation counseling
• Individual counseling

License/Certification/Accreditation

• Drug Enforcement Agency (DEA)

Facility Smoking Policy

• Smoking permitted without restriction

External Source of Medications Used for Alcohol Use Disorder Treatment

• In-network prescribing entity

Testing

• HIV testing
• Testing for Hepatitis C (HCV)
• Testing for Hepatitis B (HBV)
• Drug or alcohol urine screening
• STD testing
• Metabolic syndrome monitoring

Type of Care

• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
• Substance use treatment

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Outpatient
• Outpatient methadone/buprenorphine or naltrexone treatment

Pharmacotherapies

• Non-nicotine smoking/tobacco cessation
• Nicotine replacement
• Clonidine
• Acamprosate (Campral®)
• Buprenorphine without naloxone
• Buprenorphine with naloxone
• Medication for mental disorders
• Naltrexone (oral)
• Naltrexone (extended-release, injectable)

Type of Opioid Treatment

• Buprenorphine maintenance
• Prescribes naltrexone
• Accepts clients using MAT but prescribed elsewhere
• Prescribes buprenorphine
• Maintenance service with medically supervised withdrawal after stabilization
• Relapse prevention with naltrexone